Cargando…
Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting
PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex conce...
Autores principales: | Černý, Vladimir, Maegele, Marc, Agostini, Vanessa, Fries, Dietmar, Leal-Noval, Santiago R., Nardai, Gábor, Nardi, Giuseppe, Östlund, Anders, Schöchl, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782571/ https://www.ncbi.nlm.nih.gov/pubmed/33399876 http://dx.doi.org/10.1007/s00068-020-01563-2 |
Ejemplares similares
-
The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing
por: Kleber, Christian, et al.
Publicado: (2022) -
Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis
por: Pabinger, Ingrid, et al.
Publicado: (2017) -
Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study
por: Ziegler, Bernhard, et al.
Publicado: (2021) -
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
por: Schöchl, Herbert, et al.
Publicado: (2011) -
Early and individualized goal-directed therapy for trauma-induced coagulopathy
por: Schöchl, Herbert, et al.
Publicado: (2012)